A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient

Gretchen B. Schober,Sandra Story,Dev P. Arya

DOI: https://doi.org/10.1038/s41598-024-52685-1

IF: 4.6

2024-01-30

Scientific Reports

Abstract:With the recent success of lipid nanoparticle (LNP) based SARS-CoV-2 mRNA vaccines, the potential for RNA therapeutics has gained widespread attention. LNPs are promising non-viral delivery vectors to protect and deliver delicate RNA therapeutics, which are ineffective and susceptible to degradation alone. While food and drug administration (FDA) approved formulations have shown significant promise, benchmark lipid formulations still require optimization and improvement. In addition, the translatability of these formulations for several different RNA cargo sizes has not been compared under the same conditions. Herein we analyze "gold standard" lipid formulations for encapsulation efficiency of various non-specific RNA cargo lengths representing antisense oligonucleotides (ASO), small interfering RNA (siRNA), RNA aptamers, and messenger RNA (mRNA), with lengths of 10 bases, 21 base pairs, 96 bases, 996 bases, and 1929 bases, respectively. We evaluate encapsulation efficiency as the percentage of input RNA encapsulated in the final LNP product (EE input %), which shows discrepancy with the traditional calculation of encapsulation efficiency (EE%). EE input % is shown to be 85%. We also compared formulations for LNP size (Z-average) and polydispersity index (PDI). LNP size does not appear to be strongly influenced by cargo size, which is a counterintuitive finding. Thoughtful characterization of LNPs, in parallel with consideration of in vitro or in vivo behavior, will guide design and optimization for better understanding and improvement of future RNA therapeutics.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to address the issues of encapsulation efficiency and particle size characteristics when delivering RNA cargoes of different sizes using lipid nanoparticles (LNPs). Specifically:

1. **Evaluation of Encapsulation Efficiency**: The paper points out that existing LNP formulations may show an overestimated encapsulation efficiency (EE%) for different sizes of RNA cargoes using traditional calculation methods, as these methods do not consider the total amount of input RNA. The authors introduce a new calculation method—encapsulation efficiency based on input RNA concentration (EEinput%)—to more accurately reflect the actual encapsulation efficiency.

2. **Encapsulation Efficiency Differences for Different RNA Cargoes**: The paper investigates the encapsulation efficiency of RNA of different lengths (including antisense oligonucleotides ASO, small interfering RNA siRNA, RNA aptamers, and messenger RNA mRNA) in different LNP formulations. The results show that larger RNA molecules (such as mRNA) are more easily encapsulated than smaller RNA molecules (such as ASO and siRNA), possibly due to the higher net charge and different morphological structures of larger RNA molecules.

3. **Impact on LNP Particle Size and Polydispersity Index (PDI)**: The paper also explores the impact of different RNA cargoes on LNP particle size and polydispersity index. The study finds that the particle size and PDI of LNPs are mainly influenced by reaction conditions (such as lipid concentration and flow rate) rather than the size of the RNA cargo. However, the choice of different lipid components (such as MC3 and ALC) can affect the particle size and polydispersity of LNPs.

4. **Recommendations for Optimizing LNP Formulations**: By characterizing the encapsulation efficiency and particle size characteristics of LNPs in detail, the paper provides important references for the design and optimization of future RNA therapeutic drugs. In particular, the encapsulation efficiency calculation method that considers input RNA concentration can better guide process optimization, reducing RNA loss and associated costs.

In summary, the paper reveals the limitations of existing calculation methods through a detailed analysis of the "gold standard" LNP formulations and proposes improved calculation methods and optimization recommendations to enhance the performance of LNPs in delivering different RNA cargoes.